Jackson Square Partners LLC Has $13.33 Million Position in CME Group Inc. (NASDAQ:CME)

Jackson Square Partners LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 9.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,302 shares of the financial services provider’s stock after selling 6,789 shares during the period. Jackson Square Partners LLC’s holdings in CME Group were worth $13,331,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Allworth Financial LP increased its stake in shares of CME Group by 7.5% during the 3rd quarter. Allworth Financial LP now owns 11,421 shares of the financial services provider’s stock worth $2,287,000 after purchasing an additional 793 shares during the last quarter. Teacher Retirement System of Texas boosted its holdings in CME Group by 35.3% in the third quarter. Teacher Retirement System of Texas now owns 159,084 shares of the financial services provider’s stock worth $31,852,000 after purchasing an additional 41,518 shares in the last quarter. Dearborn Partners LLC increased its position in CME Group by 67.4% during the third quarter. Dearborn Partners LLC now owns 2,862 shares of the financial services provider’s stock worth $573,000 after buying an additional 1,152 shares during the last quarter. Wealthfront Advisers LLC raised its holdings in CME Group by 26.8% during the third quarter. Wealthfront Advisers LLC now owns 45,584 shares of the financial services provider’s stock valued at $9,127,000 after buying an additional 9,646 shares in the last quarter. Finally, Wakefield Asset Management LLLP acquired a new stake in shares of CME Group in the third quarter worth about $264,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ:CME traded up $0.41 during midday trading on Friday, reaching $213.14. 1,466,368 shares of the company’s stock were exchanged, compared to its average volume of 1,831,731. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. The company’s 50 day simple moving average is $212.46 and its two-hundred day simple moving average is $211.34. CME Group Inc. has a 12 month low of $175.73 and a 12 month high of $223.80. The firm has a market capitalization of $76.75 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 5.63 and a beta of 0.48.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s revenue was up 3.2% on a year-over-year basis. During the same period last year, the business earned $2.42 earnings per share. Equities research analysts expect that CME Group Inc. will post 9.72 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s payout ratio is 52.33%.

Insider Activity

In other CME Group news, CEO Terrence A. Duffy sold 40,000 shares of the business’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the transaction, the chief executive officer now owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other CME Group news, Director Terry L. Savage sold 2,500 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now directly owns 17,441 shares in the company, valued at approximately $3,673,946.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 40,000 shares of the business’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now owns 67,455 shares of the company’s stock, valued at approximately $14,226,934.05. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 49,640 shares of company stock worth $10,464,924. Insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. JPMorgan Chase & Co. raised their price objective on CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Argus raised their price target on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $210.00 price objective (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Keefe, Bruyette & Woods raised their target price on CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a report on Thursday, April 25th. Finally, Bank of America upped their price target on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $217.80.

Check Out Our Latest Research Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.